Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David E. Lyons is active.

Publication


Featured researches published by David E. Lyons.


Archives of Biochemistry and Biophysics | 1992

Purification and characterization of soluble forms of human and rat stem cell factor recombinantly expressed by Escherichia coli and by Chinese hamster ovary cells

Keith E. Langley; Elizabeth A. Mendiaz; Christi L. Clogston; Vann P. Parker; Douglas H. Farrar; Vasuki N. Satygal; Ian Leslie; Neal C. Birkett; Kent A. Smith; Robert F. Baltera; David E. Lyons; Jeffery M. Hogan; Craig Crandall; Thomas C. Boone; Joseph Pope; Subhash Karkare; Krisztina M. Zsebo; Raj Sachdev; Hsieng S. Lu

Stem cell factor (SCF) is a novel, early-acting hematopoietic factor. It was isolated from the medium of a rat cell line in a soluble, processed form (Zsebo et al., 1990, Cell 63, 195). The cloned human and rat genes encode the soluble form plus additional C-terminal amino acids including a hydrophobic transmembrane domain (Martin et al., 1990, Cell 63, 203). We have recombinantly expressed forms of human and rat SCF corresponding to the soluble, processed form in Escherichia coli and in Chinese hamster ovary (CHO) cells. After expression in E. coli, folding and oxidation of the SCF polypeptides are required. The SCFs expressed in CHO cells are secreted into the medium in active state and, like the natural SCF, are glycosylated. Purification of the recombinant SCFs is described. Biological and biochemical characterization includes activity toward responsive human and mouse cell lines, N-terminal amino acid sequences, disulfide bond linkages, and sites of glycosylation.


Techniques in Protein Chemistry | 1996

Disulfide characterization of CD31 (PECAM)

John H. Robinson; Michael D. McGinley; J. Christopher Leidli; David E. Lyons; Chi-Hwei Lin; Barbara Karan-Tamir; Mark M. Zukowski; Michael F. Rohde

Publisher Summary This chapter describes the disulfide characterization of CD31 (PECAM). CD31 is a 100 kDa integral membrane glycoprotein found in endothelial intercellular junctions, platelets, and monocytes. CD31 is believed to be involved in the regulation of endothelial cell migration, thus it is probably involved in vascular development, wound repair, and angiogenesis. Although binding of CD31 is homophilic, there is some evidence that it may bind other members of the cellular adhesion molecule family. Common to the adhesion molecules is the immunoglobulin (Ig) homology unit that consists of two β-sheets stabilized by a disulfide bond. Few adhesion molecule disulfide structures are determined in the chapter. Most disulfide structures are assumed by structural homology with other proteins in the same family or superfamily. The adhesion molecules are relatively, hydrophobic, and heavily glycosylated. Deglycosylation of the native protein ( N - and O - sites) reduce the complexity of peptide maps and simplify mass spectral data, allowing for simpler disulfide assignments.


Archives of Surgery | 1999

Vascular Endothelial Growth Factor Is More Important Than Basic Fibroblastic Growth Factor During Ischemic Wound Healing

Claudio J. Corral; Aamir Siddiqui; Liancun Wu; Catherine L. Farrell; David E. Lyons; Thomas A. Mustoe


Biochemical and Biophysical Research Communications | 1997

The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA.

Ralph J. Zitnik; Jue Zhang; Mohammed A. Kashem; Tadahiko Kohno; David E. Lyons; Clifford D. Wright; Eliot M. Rosen; Itzhak D. Goldberg; Adrian Hayday


Archive | 1994

Mammal with enhanced liver expression of a transgene

William Scott Simonet; Henri Lichenstein; David E. Lyons


Protein Expression and Purification | 1996

Isolation and Characterization of Human Tissue Kallikrein Produced inEscherichia coli:Biochemical Comparison to the Enzymatically Inactive Prokallikrein and Methionyl Kallikrein

Hsieng S. Lu; Yueh-Rong Hsu; Louise I. Lu; David Ruff; David E. Lyons; Fu-Kuen Lin


Archive | 1990

PRODUCTION OF BIOLOGICALLY ACTIVE PLATELET-DERIVED GROWTH FACTOR FROM HIGH EXPRESSION HOST CELL SYSTEMS.

David E. Lyons; Arlen R. Thomason


International Journal of Peptide and Protein Research | 2009

Conformation of glutathione adduct and oxidized forms of platelet-derived growth factor

Linda O. Narhi; William C. Kenney; Steven J. Prestrelski; Tsutomu Arakawa; David E. Lyons; Jeffrey W. Lary; David A. Yphantis


Archive | 1994

Production of platelet-derived growth factor B-chain heterodimers from high expression host cell system

David E. Lyons; Arlen R. Thomason


Archive | 1995

Afamin: ein menschliches serum albumin ähnliches protein Afamin: a human serum albumin-like protein

Henri Lichenstein; David E. Lyons; Mark Matsuo Wurfel; Samuel D. Wright

Collaboration


Dive into the David E. Lyons's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Itzhak D. Goldberg

Albert Einstein College of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge